Illumina Body Map 2
Gene Symbol | Gene ID | Gene Info |
---|---|---|
TFAP2C
|
ENSG00000087510.5 | transcription factor AP-2 gamma |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
TFAP2C | hg19_v2_chr20_+_55205825_55205938 | 0.54 | 1.3e-03 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_54676884 | 2.41 |
ENST00000376591.4
|
TMC4
|
transmembrane channel-like 4 |
chr9_-_115653176 | 2.05 |
ENST00000374228.4
|
SLC46A2
|
solute carrier family 46, member 2 |
chrX_+_101380642 | 1.90 |
ENST00000372780.1
ENST00000329035.2 |
TCEAL2
|
transcription elongation factor A (SII)-like 2 |
chr9_-_140064496 | 1.85 |
ENST00000371542.3
|
LRRC26
|
leucine rich repeat containing 26 |
chr8_-_11324273 | 1.83 |
ENST00000284486.4
|
FAM167A
|
family with sequence similarity 167, member A |
chr4_-_57522673 | 1.74 |
ENST00000381255.3
ENST00000317745.7 ENST00000555760.2 ENST00000556614.2 |
HOPX
|
HOP homeobox |
chr12_-_52914155 | 1.73 |
ENST00000549420.1
ENST00000551275.1 ENST00000546577.1 |
KRT5
|
keratin 5 |
chr1_+_206317450 | 1.58 |
ENST00000358184.2
ENST00000361052.3 ENST00000360218.2 |
CTSE
|
cathepsin E |
chr19_-_54676846 | 1.57 |
ENST00000301187.4
|
TMC4
|
transmembrane channel-like 4 |
chr20_-_18038521 | 1.57 |
ENST00000278780.6
|
OVOL2
|
ovo-like zinc finger 2 |
chr4_+_55524085 | 1.57 |
ENST00000412167.2
ENST00000288135.5 |
KIT
|
v-kit Hardy-Zuckerman 4 feline sarcoma viral oncogene homolog |
chr6_-_31846744 | 1.53 |
ENST00000414427.1
ENST00000229729.6 ENST00000375562.4 |
SLC44A4
|
solute carrier family 44, member 4 |
chr19_-_39264072 | 1.52 |
ENST00000599035.1
ENST00000378626.4 |
LGALS7
|
lectin, galactoside-binding, soluble, 7 |
chr4_-_57522598 | 1.51 |
ENST00000553379.2
|
HOPX
|
HOP homeobox |
chr1_+_207627575 | 1.49 |
ENST00000367058.3
ENST00000367057.3 ENST00000367059.3 |
CR2
|
complement component (3d/Epstein Barr virus) receptor 2 |
chr17_-_39684550 | 1.49 |
ENST00000455635.1
ENST00000361566.3 |
KRT19
|
keratin 19 |
chr21_-_42880075 | 1.48 |
ENST00000332149.5
|
TMPRSS2
|
transmembrane protease, serine 2 |
chr20_+_55205825 | 1.47 |
ENST00000544508.1
|
TFAP2C
|
transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma) |
chr15_+_41136586 | 1.47 |
ENST00000431806.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr1_-_27286897 | 1.41 |
ENST00000320567.5
|
C1orf172
|
chromosome 1 open reading frame 172 |
chr20_+_57594309 | 1.39 |
ENST00000217133.1
|
TUBB1
|
tubulin, beta 1 class VI |
chr2_-_85895295 | 1.39 |
ENST00000428225.1
ENST00000519937.2 |
SFTPB
|
surfactant protein B |
chr19_+_35607166 | 1.37 |
ENST00000604255.1
ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3
|
FXYD domain containing ion transport regulator 3 |
chr19_-_38747172 | 1.36 |
ENST00000347262.4
ENST00000591585.1 ENST00000301242.4 |
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr21_-_42879909 | 1.34 |
ENST00000458356.1
ENST00000398585.3 ENST00000424093.1 |
TMPRSS2
|
transmembrane protease, serine 2 |
chr21_-_46348694 | 1.33 |
ENST00000355153.4
ENST00000397850.2 |
ITGB2
|
integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
chrX_-_129244336 | 1.33 |
ENST00000434609.1
|
ELF4
|
E74-like factor 4 (ets domain transcription factor) |
chr20_+_31870927 | 1.32 |
ENST00000253354.1
|
BPIFB1
|
BPI fold containing family B, member 1 |
chr7_+_12610307 | 1.31 |
ENST00000297029.5
|
SCIN
|
scinderin |
chr19_+_751122 | 1.29 |
ENST00000215582.6
|
MISP
|
mitotic spindle positioning |
chr6_+_13925098 | 1.28 |
ENST00000488300.1
ENST00000544682.1 ENST00000420478.2 |
RNF182
|
ring finger protein 182 |
chr5_-_172755056 | 1.28 |
ENST00000520648.1
|
STC2
|
stanniocalcin 2 |
chr20_+_37434329 | 1.28 |
ENST00000299824.1
ENST00000373331.2 |
PPP1R16B
|
protein phosphatase 1, regulatory subunit 16B |
chr11_+_35160709 | 1.28 |
ENST00000415148.2
ENST00000433354.2 ENST00000449691.2 ENST00000437706.2 ENST00000360158.4 ENST00000428726.2 ENST00000526669.2 ENST00000433892.2 ENST00000278386.6 ENST00000434472.2 ENST00000352818.4 ENST00000442151.2 |
CD44
|
CD44 molecule (Indian blood group) |
chr6_-_32731243 | 1.24 |
ENST00000427449.1
ENST00000411527.1 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr16_+_30485267 | 1.23 |
ENST00000569725.1
|
ITGAL
|
integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
chr13_-_20806440 | 1.23 |
ENST00000400066.3
ENST00000400065.3 ENST00000356192.6 |
GJB6
|
gap junction protein, beta 6, 30kDa |
chr19_-_38743878 | 1.23 |
ENST00000587515.1
|
PPP1R14A
|
protein phosphatase 1, regulatory (inhibitor) subunit 14A |
chr19_+_39279838 | 1.21 |
ENST00000314980.4
|
LGALS7B
|
lectin, galactoside-binding, soluble, 7B |
chr9_-_94712434 | 1.21 |
ENST00000375708.3
|
ROR2
|
receptor tyrosine kinase-like orphan receptor 2 |
chr16_+_81478775 | 1.20 |
ENST00000537098.3
|
CMIP
|
c-Maf inducing protein |
chr4_+_106473768 | 1.18 |
ENST00000265154.2
ENST00000420470.2 |
ARHGEF38
|
Rho guanine nucleotide exchange factor (GEF) 38 |
chr17_-_79139817 | 1.18 |
ENST00000326724.4
|
AATK
|
apoptosis-associated tyrosine kinase |
chr12_-_53207842 | 1.18 |
ENST00000458244.2
|
KRT4
|
keratin 4 |
chr6_+_135502501 | 1.17 |
ENST00000527615.1
ENST00000420123.2 ENST00000525369.1 ENST00000528774.1 ENST00000534121.1 ENST00000534044.1 ENST00000533624.1 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr21_+_34442439 | 1.16 |
ENST00000382348.1
ENST00000333063.5 |
OLIG1
|
oligodendrocyte transcription factor 1 |
chr19_-_49137790 | 1.15 |
ENST00000599385.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr2_+_47596634 | 1.14 |
ENST00000419334.1
|
EPCAM
|
epithelial cell adhesion molecule |
chr4_+_85504075 | 1.13 |
ENST00000295887.5
|
CDS1
|
CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 1 |
chr20_-_52790512 | 1.13 |
ENST00000216862.3
|
CYP24A1
|
cytochrome P450, family 24, subfamily A, polypeptide 1 |
chr1_+_206317591 | 1.13 |
ENST00000432969.2
|
CTSE
|
cathepsin E |
chr6_-_32731299 | 1.13 |
ENST00000435145.2
ENST00000437316.2 |
HLA-DQB2
|
major histocompatibility complex, class II, DQ beta 2 |
chr11_-_47400062 | 1.13 |
ENST00000533030.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr20_+_44098385 | 1.13 |
ENST00000217425.5
ENST00000339946.3 |
WFDC2
|
WAP four-disulfide core domain 2 |
chr1_+_19970797 | 1.13 |
ENST00000548815.1
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr16_+_215965 | 1.12 |
ENST00000356815.3
|
HBM
|
hemoglobin, mu |
chr1_-_41950342 | 1.12 |
ENST00000372587.4
|
EDN2
|
endothelin 2 |
chr11_+_46402583 | 1.11 |
ENST00000359803.3
|
MDK
|
midkine (neurite growth-promoting factor 2) |
chrX_-_50557302 | 1.11 |
ENST00000289292.7
|
SHROOM4
|
shroom family member 4 |
chr3_-_46506563 | 1.11 |
ENST00000231751.4
|
LTF
|
lactotransferrin |
chr16_-_11680791 | 1.11 |
ENST00000571976.1
ENST00000413364.2 |
LITAF
|
lipopolysaccharide-induced TNF factor |
chr15_+_41136734 | 1.10 |
ENST00000568580.1
|
SPINT1
|
serine peptidase inhibitor, Kunitz type 1 |
chr20_+_44098346 | 1.10 |
ENST00000372676.3
|
WFDC2
|
WAP four-disulfide core domain 2 |
chr17_-_39769005 | 1.09 |
ENST00000301653.4
ENST00000593067.1 |
KRT16
|
keratin 16 |
chr15_-_45422056 | 1.09 |
ENST00000267803.4
ENST00000559014.1 ENST00000558851.1 ENST00000559988.1 ENST00000558996.1 ENST00000558422.1 ENST00000559226.1 ENST00000558326.1 ENST00000558377.1 ENST00000559644.1 |
DUOXA1
|
dual oxidase maturation factor 1 |
chr19_-_35992780 | 1.09 |
ENST00000593342.1
ENST00000601650.1 ENST00000408915.2 |
DMKN
|
dermokine |
chr17_+_59529743 | 1.08 |
ENST00000589003.1
ENST00000393853.4 |
TBX4
|
T-box 4 |
chr17_-_74137374 | 1.07 |
ENST00000322957.6
|
FOXJ1
|
forkhead box J1 |
chr7_-_111846435 | 1.06 |
ENST00000437633.1
ENST00000428084.1 |
DOCK4
|
dedicator of cytokinesis 4 |
chr1_-_111217603 | 1.06 |
ENST00000369769.2
|
KCNA3
|
potassium voltage-gated channel, shaker-related subfamily, member 3 |
chr1_+_2407754 | 1.06 |
ENST00000419816.2
ENST00000378486.3 ENST00000378488.3 ENST00000288766.5 |
PLCH2
|
phospholipase C, eta 2 |
chr3_+_112051994 | 1.05 |
ENST00000473539.1
ENST00000315711.8 ENST00000383681.3 |
CD200
|
CD200 molecule |
chr11_+_118826999 | 1.05 |
ENST00000264031.2
|
UPK2
|
uroplakin 2 |
chr19_-_10628117 | 1.04 |
ENST00000333430.4
|
S1PR5
|
sphingosine-1-phosphate receptor 5 |
chr14_-_106330458 | 1.03 |
ENST00000461719.1
|
IGHJ4
|
immunoglobulin heavy joining 4 |
chr3_+_105086056 | 1.03 |
ENST00000472644.2
|
ALCAM
|
activated leukocyte cell adhesion molecule |
chr16_+_23194033 | 1.03 |
ENST00000300061.2
|
SCNN1G
|
sodium channel, non-voltage-gated 1, gamma subunit |
chr9_-_80263220 | 1.03 |
ENST00000341700.6
|
GNA14
|
guanine nucleotide binding protein (G protein), alpha 14 |
chr19_-_10697895 | 1.03 |
ENST00000591240.1
ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2
|
adaptor-related protein complex 1, mu 2 subunit |
chr14_-_106878083 | 1.02 |
ENST00000390619.2
|
IGHV4-39
|
immunoglobulin heavy variable 4-39 |
chr11_+_129245796 | 1.02 |
ENST00000281437.4
|
BARX2
|
BARX homeobox 2 |
chr3_-_50540854 | 1.01 |
ENST00000423994.2
ENST00000424201.2 ENST00000479441.1 ENST00000429770.1 |
CACNA2D2
|
calcium channel, voltage-dependent, alpha 2/delta subunit 2 |
chr6_-_167370049 | 1.00 |
ENST00000366855.6
ENST00000508775.1 |
RNASET2
|
ribonuclease T2 |
chr19_-_14629224 | 0.99 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr12_-_28123206 | 0.99 |
ENST00000542963.1
ENST00000535992.1 |
PTHLH
|
parathyroid hormone-like hormone |
chr22_+_22385332 | 0.98 |
ENST00000390282.2
|
IGLV4-69
|
immunoglobulin lambda variable 4-69 |
chr2_+_105471969 | 0.98 |
ENST00000361360.2
|
POU3F3
|
POU class 3 homeobox 3 |
chr6_-_117086873 | 0.98 |
ENST00000368557.4
|
FAM162B
|
family with sequence similarity 162, member B |
chr14_-_107114267 | 0.97 |
ENST00000454421.2
|
IGHV3-64
|
immunoglobulin heavy variable 3-64 |
chr1_-_153521714 | 0.96 |
ENST00000368713.3
|
S100A3
|
S100 calcium binding protein A3 |
chr19_+_45973120 | 0.95 |
ENST00000592811.1
ENST00000586615.1 |
FOSB
|
FBJ murine osteosarcoma viral oncogene homolog B |
chr11_-_64612041 | 0.94 |
ENST00000342711.5
|
CDC42BPG
|
CDC42 binding protein kinase gamma (DMPK-like) |
chr2_+_206950095 | 0.94 |
ENST00000435627.1
|
AC007383.3
|
AC007383.3 |
chr2_+_196521845 | 0.94 |
ENST00000359634.5
ENST00000412905.1 |
SLC39A10
|
solute carrier family 39 (zinc transporter), member 10 |
chr9_+_139221880 | 0.94 |
ENST00000392945.3
ENST00000440944.1 |
GPSM1
|
G-protein signaling modulator 1 |
chr7_+_100464760 | 0.93 |
ENST00000200457.4
|
TRIP6
|
thyroid hormone receptor interactor 6 |
chr6_+_151187074 | 0.92 |
ENST00000367308.4
|
MTHFD1L
|
methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like |
chr2_-_235405168 | 0.92 |
ENST00000339728.3
|
ARL4C
|
ADP-ribosylation factor-like 4C |
chr17_+_4402133 | 0.92 |
ENST00000329078.3
|
SPNS2
|
spinster homolog 2 (Drosophila) |
chr19_-_7939319 | 0.92 |
ENST00000539422.1
|
CTD-3193O13.9
|
Protein FLJ22184 |
chr9_+_17579084 | 0.91 |
ENST00000380607.4
|
SH3GL2
|
SH3-domain GRB2-like 2 |
chr17_+_11501748 | 0.91 |
ENST00000262442.4
ENST00000579828.1 |
DNAH9
|
dynein, axonemal, heavy chain 9 |
chr10_-_104179682 | 0.91 |
ENST00000406432.1
|
PSD
|
pleckstrin and Sec7 domain containing |
chr16_+_69139467 | 0.91 |
ENST00000569188.1
|
HAS3
|
hyaluronan synthase 3 |
chrX_+_115567767 | 0.90 |
ENST00000371900.4
|
SLC6A14
|
solute carrier family 6 (amino acid transporter), member 14 |
chr1_-_156217829 | 0.90 |
ENST00000356983.2
ENST00000335852.1 ENST00000340183.5 ENST00000540423.1 |
PAQR6
|
progestin and adipoQ receptor family member VI |
chr6_+_43044003 | 0.90 |
ENST00000230419.4
ENST00000476760.1 ENST00000471863.1 ENST00000349241.2 ENST00000352931.2 ENST00000345201.2 |
PTK7
|
protein tyrosine kinase 7 |
chr22_+_23222886 | 0.90 |
ENST00000390319.2
|
IGLV3-1
|
immunoglobulin lambda variable 3-1 |
chr11_-_47400078 | 0.89 |
ENST00000378538.3
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr15_+_81293254 | 0.89 |
ENST00000267984.2
|
MESDC1
|
mesoderm development candidate 1 |
chr1_+_192778161 | 0.89 |
ENST00000235382.5
|
RGS2
|
regulator of G-protein signaling 2, 24kDa |
chr19_-_49137762 | 0.89 |
ENST00000593500.1
|
DBP
|
D site of albumin promoter (albumin D-box) binding protein |
chr6_+_45389893 | 0.88 |
ENST00000371432.3
|
RUNX2
|
runt-related transcription factor 2 |
chrX_+_153237740 | 0.88 |
ENST00000369982.4
|
TMEM187
|
transmembrane protein 187 |
chr2_+_27665232 | 0.88 |
ENST00000543753.1
ENST00000288873.3 |
KRTCAP3
|
keratinocyte associated protein 3 |
chr6_+_31554779 | 0.88 |
ENST00000376090.2
|
LST1
|
leukocyte specific transcript 1 |
chr4_-_5894777 | 0.88 |
ENST00000324989.7
|
CRMP1
|
collapsin response mediator protein 1 |
chr5_-_74348371 | 0.87 |
ENST00000503568.1
|
RP11-229C3.2
|
RP11-229C3.2 |
chr17_-_34524157 | 0.87 |
ENST00000378354.4
ENST00000394484.1 |
CCL3L3
|
chemokine (C-C motif) ligand 3-like 3 |
chr8_-_22014255 | 0.87 |
ENST00000424267.2
|
LGI3
|
leucine-rich repeat LGI family, member 3 |
chr12_+_52301175 | 0.87 |
ENST00000388922.4
|
ACVRL1
|
activin A receptor type II-like 1 |
chr10_-_48438974 | 0.87 |
ENST00000224605.2
|
GDF10
|
growth differentiation factor 10 |
chr4_+_2043689 | 0.87 |
ENST00000382878.3
ENST00000409248.4 |
C4orf48
|
chromosome 4 open reading frame 48 |
chr6_+_13272904 | 0.86 |
ENST00000379335.3
ENST00000379329.1 |
PHACTR1
|
phosphatase and actin regulator 1 |
chr4_+_4861385 | 0.86 |
ENST00000382723.4
|
MSX1
|
msh homeobox 1 |
chr14_-_106174960 | 0.86 |
ENST00000390547.2
|
IGHA1
|
immunoglobulin heavy constant alpha 1 |
chr16_-_31146961 | 0.86 |
ENST00000567531.1
|
PRSS8
|
protease, serine, 8 |
chr17_-_34079897 | 0.86 |
ENST00000254466.6
ENST00000587565.1 |
GAS2L2
|
growth arrest-specific 2 like 2 |
chr7_+_73242069 | 0.85 |
ENST00000435050.1
|
CLDN4
|
claudin 4 |
chr6_+_135502408 | 0.85 |
ENST00000341911.5
ENST00000442647.2 ENST00000316528.8 |
MYB
|
v-myb avian myeloblastosis viral oncogene homolog |
chr11_-_47400032 | 0.85 |
ENST00000533968.1
|
SPI1
|
spleen focus forming virus (SFFV) proviral integration oncogene |
chr1_-_207119738 | 0.85 |
ENST00000356495.4
|
PIGR
|
polymeric immunoglobulin receptor |
chr11_+_1856034 | 0.85 |
ENST00000341958.3
|
SYT8
|
synaptotagmin VIII |
chr3_-_46506358 | 0.85 |
ENST00000417439.1
ENST00000431944.1 |
LTF
|
lactotransferrin |
chr7_+_73245193 | 0.84 |
ENST00000340958.2
|
CLDN4
|
claudin 4 |
chr17_+_8339164 | 0.84 |
ENST00000582665.1
ENST00000334527.7 ENST00000299734.7 |
NDEL1
|
nudE neurodevelopment protein 1-like 1 |
chr19_-_42947121 | 0.84 |
ENST00000601181.1
|
CXCL17
|
chemokine (C-X-C motif) ligand 17 |
chr19_-_6767516 | 0.84 |
ENST00000245908.6
|
SH2D3A
|
SH2 domain containing 3A |
chr21_-_43916433 | 0.84 |
ENST00000291536.3
|
RSPH1
|
radial spoke head 1 homolog (Chlamydomonas) |
chr19_+_5914213 | 0.83 |
ENST00000222125.5
ENST00000452990.2 ENST00000588865.1 |
CAPS
|
calcyphosine |
chr12_-_52887034 | 0.83 |
ENST00000330722.6
|
KRT6A
|
keratin 6A |
chr20_+_3776936 | 0.83 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
chr19_-_51529849 | 0.83 |
ENST00000600362.1
ENST00000453757.3 ENST00000601671.1 |
KLK11
|
kallikrein-related peptidase 11 |
chr7_-_86849883 | 0.83 |
ENST00000433078.1
|
TMEM243
|
transmembrane protein 243, mitochondrial |
chr22_+_23063100 | 0.83 |
ENST00000390309.2
|
IGLV3-19
|
immunoglobulin lambda variable 3-19 |
chr4_-_87515202 | 0.83 |
ENST00000502302.1
ENST00000513186.1 |
MAPK10
|
mitogen-activated protein kinase 10 |
chrX_-_13956737 | 0.83 |
ENST00000454189.2
|
GPM6B
|
glycoprotein M6B |
chr3_-_185542817 | 0.82 |
ENST00000382199.2
|
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr15_+_45422131 | 0.82 |
ENST00000321429.4
|
DUOX1
|
dual oxidase 1 |
chr17_-_39681578 | 0.82 |
ENST00000593096.1
|
KRT19
|
keratin 19 |
chr16_+_68679193 | 0.82 |
ENST00000581171.1
|
CDH3
|
cadherin 3, type 1, P-cadherin (placental) |
chr22_+_32340481 | 0.82 |
ENST00000397492.1
|
YWHAH
|
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta |
chr4_+_153857468 | 0.82 |
ENST00000511601.1
|
FHDC1
|
FH2 domain containing 1 |
chr11_+_66045634 | 0.82 |
ENST00000528852.1
ENST00000311445.6 |
CNIH2
|
cornichon family AMPA receptor auxiliary protein 2 |
chr7_-_149470540 | 0.81 |
ENST00000302017.3
|
ZNF467
|
zinc finger protein 467 |
chr17_-_4463856 | 0.81 |
ENST00000574584.1
ENST00000381550.3 ENST00000301395.3 |
GGT6
|
gamma-glutamyltransferase 6 |
chr1_+_19970657 | 0.81 |
ENST00000375136.3
|
NBL1
|
neuroblastoma 1, DAN family BMP antagonist |
chr1_+_207627697 | 0.80 |
ENST00000458541.2
|
CR2
|
complement component (3d/Epstein Barr virus) receptor 2 |
chr15_+_45422178 | 0.80 |
ENST00000389037.3
ENST00000558322.1 |
DUOX1
|
dual oxidase 1 |
chr3_-_185542761 | 0.79 |
ENST00000457616.2
ENST00000346192.3 |
IGF2BP2
|
insulin-like growth factor 2 mRNA binding protein 2 |
chr7_-_56184093 | 0.79 |
ENST00000329309.3
|
NUPR1L
|
nuclear protein, transcriptional regulator, 1-like |
chr4_+_74606223 | 0.79 |
ENST00000307407.3
ENST00000401931.1 |
IL8
|
interleukin 8 |
chr16_-_11681316 | 0.79 |
ENST00000571688.1
|
LITAF
|
lipopolysaccharide-induced TNF factor |
chr17_+_8339340 | 0.79 |
ENST00000580012.1
|
NDEL1
|
nudE neurodevelopment protein 1-like 1 |
chr2_-_20212422 | 0.79 |
ENST00000421259.2
ENST00000407540.3 |
MATN3
|
matrilin 3 |
chr4_+_102711764 | 0.79 |
ENST00000322953.4
ENST00000428908.1 |
BANK1
|
B-cell scaffold protein with ankyrin repeats 1 |
chr2_-_214017151 | 0.79 |
ENST00000452786.1
|
IKZF2
|
IKAROS family zinc finger 2 (Helios) |
chr6_-_132722604 | 0.78 |
ENST00000392401.3
ENST00000367963.3 |
MOXD1
|
monooxygenase, DBH-like 1 |
chr1_+_26872324 | 0.78 |
ENST00000531382.1
|
RPS6KA1
|
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
chr19_-_39832563 | 0.78 |
ENST00000599274.1
|
CTC-246B18.10
|
CTC-246B18.10 |
chr1_+_65775204 | 0.78 |
ENST00000371069.4
|
DNAJC6
|
DnaJ (Hsp40) homolog, subfamily C, member 6 |
chr1_+_26644441 | 0.78 |
ENST00000374213.2
|
CD52
|
CD52 molecule |
chr7_+_12610338 | 0.78 |
ENST00000417018.1
|
SCIN
|
scinderin |
chr19_-_49016847 | 0.77 |
ENST00000598924.1
|
CTC-273B12.10
|
CTC-273B12.10 |
chr4_-_103266219 | 0.77 |
ENST00000394833.2
|
SLC39A8
|
solute carrier family 39 (zinc transporter), member 8 |
chr20_-_54580523 | 0.77 |
ENST00000064571.2
|
CBLN4
|
cerebellin 4 precursor |
chr22_+_23161491 | 0.77 |
ENST00000390316.2
|
IGLV3-9
|
immunoglobulin lambda variable 3-9 (gene/pseudogene) |
chr15_+_91427691 | 0.77 |
ENST00000559355.1
ENST00000394302.1 |
FES
|
feline sarcoma oncogene |
chr10_-_100174900 | 0.77 |
ENST00000370575.4
|
PYROXD2
|
pyridine nucleotide-disulphide oxidoreductase domain 2 |
chr10_+_115803650 | 0.76 |
ENST00000369295.2
|
ADRB1
|
adrenoceptor beta 1 |
chr7_-_86849025 | 0.76 |
ENST00000257637.3
|
TMEM243
|
transmembrane protein 243, mitochondrial |
chr6_+_36098262 | 0.76 |
ENST00000373761.6
ENST00000373766.5 |
MAPK13
|
mitogen-activated protein kinase 13 |
chr8_+_142138711 | 0.76 |
ENST00000518347.1
ENST00000262585.2 ENST00000424248.1 ENST00000519811.1 ENST00000520986.1 ENST00000523058.1 |
DENND3
|
DENN/MADD domain containing 3 |
chr16_-_776431 | 0.75 |
ENST00000293889.6
|
CCDC78
|
coiled-coil domain containing 78 |
chr14_-_106967788 | 0.75 |
ENST00000390622.2
|
IGHV1-46
|
immunoglobulin heavy variable 1-46 |
chr12_+_48178706 | 0.75 |
ENST00000599515.1
|
AC004466.1
|
Uncharacterized protein |
chr16_+_4845379 | 0.75 |
ENST00000588606.1
ENST00000586005.1 |
SMIM22
|
small integral membrane protein 22 |
chr1_-_153521597 | 0.75 |
ENST00000368712.1
|
S100A3
|
S100 calcium binding protein A3 |
chr4_+_74702214 | 0.75 |
ENST00000226317.5
ENST00000515050.1 |
CXCL6
|
chemokine (C-X-C motif) ligand 6 |
chr16_-_88717423 | 0.74 |
ENST00000568278.1
ENST00000569359.1 ENST00000567174.1 |
CYBA
|
cytochrome b-245, alpha polypeptide |
chr11_+_66512089 | 0.74 |
ENST00000524551.1
ENST00000525908.1 ENST00000360962.4 ENST00000346672.4 ENST00000527634.1 ENST00000540737.1 |
C11orf80
|
chromosome 11 open reading frame 80 |
chr6_+_14117872 | 0.73 |
ENST00000379153.3
|
CD83
|
CD83 molecule |
chr14_+_75988768 | 0.73 |
ENST00000286639.6
|
BATF
|
basic leucine zipper transcription factor, ATF-like |
chr2_-_135476552 | 0.73 |
ENST00000281924.6
|
TMEM163
|
transmembrane protein 163 |
chr2_+_27665289 | 0.73 |
ENST00000407293.1
|
KRTCAP3
|
keratinocyte associated protein 3 |
chr19_-_19754404 | 0.73 |
ENST00000587205.1
ENST00000445806.2 ENST00000203556.4 |
GMIP
|
GEM interacting protein |
chr3_+_71803201 | 0.73 |
ENST00000304411.2
|
GPR27
|
G protein-coupled receptor 27 |
chr17_-_39677971 | 0.72 |
ENST00000393976.2
|
KRT15
|
keratin 15 |
chr20_+_3777078 | 0.72 |
ENST00000340833.4
|
CDC25B
|
cell division cycle 25B |
chr11_+_68451943 | 0.72 |
ENST00000265643.3
|
GAL
|
galanin/GMAP prepropeptide |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.9 | 2.6 | GO:0033214 | iron assimilation(GO:0033212) iron assimilation by chelation and transport(GO:0033214) positive regulation of bone mineralization involved in bone maturation(GO:1900159) negative regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000308) |
0.9 | 2.6 | GO:1990922 | regulation of hepatic stellate cell proliferation(GO:1904897) positive regulation of hepatic stellate cell proliferation(GO:1904899) hepatic stellate cell proliferation(GO:1990922) |
0.7 | 3.4 | GO:0044027 | hypermethylation of CpG island(GO:0044027) |
0.6 | 1.9 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
0.5 | 1.6 | GO:0038162 | erythropoietin-mediated signaling pathway(GO:0038162) |
0.5 | 1.6 | GO:1902309 | negative regulation of peptidyl-serine dephosphorylation(GO:1902309) |
0.5 | 1.5 | GO:0048925 | lateral line system development(GO:0048925) |
0.5 | 2.8 | GO:0030421 | defecation(GO:0030421) |
0.4 | 1.3 | GO:0048210 | Golgi vesicle fusion to target membrane(GO:0048210) |
0.4 | 2.1 | GO:1903613 | regulation of protein tyrosine phosphatase activity(GO:1903613) positive regulation of protein tyrosine phosphatase activity(GO:1903615) |
0.4 | 1.6 | GO:0042369 | vitamin D catabolic process(GO:0042369) |
0.4 | 0.4 | GO:0001300 | chronological cell aging(GO:0001300) |
0.4 | 1.9 | GO:0038098 | sequestering of BMP from receptor via BMP binding(GO:0038098) |
0.4 | 0.7 | GO:0051795 | positive regulation of catagen(GO:0051795) |
0.4 | 1.1 | GO:0002661 | B cell tolerance induction(GO:0002514) regulation of B cell tolerance induction(GO:0002661) positive regulation of B cell tolerance induction(GO:0002663) |
0.4 | 1.1 | GO:0002372 | myeloid dendritic cell cytokine production(GO:0002372) |
0.3 | 1.0 | GO:0035604 | fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow(GO:0035602) fibroblast growth factor receptor signaling pathway involved in hemopoiesis(GO:0035603) fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow(GO:0035604) |
0.3 | 2.4 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.3 | 1.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.3 | 1.0 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.3 | 2.1 | GO:0019322 | pentose biosynthetic process(GO:0019322) |
0.3 | 0.9 | GO:1904617 | negative regulation of actin filament binding(GO:1904530) negative regulation of actin binding(GO:1904617) |
0.3 | 1.4 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.3 | 1.2 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.3 | 0.9 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) |
0.3 | 0.9 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 1.6 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.3 | 0.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.3 | 1.6 | GO:0042335 | cuticle development(GO:0042335) |
0.3 | 1.6 | GO:0060214 | endocardium formation(GO:0060214) |
0.3 | 3.1 | GO:0060052 | neurofilament cytoskeleton organization(GO:0060052) |
0.3 | 0.8 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.3 | 1.8 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.3 | 3.3 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.3 | 0.8 | GO:0034164 | negative regulation of toll-like receptor 9 signaling pathway(GO:0034164) |
0.3 | 1.3 | GO:0090285 | negative regulation of protein glycosylation in Golgi(GO:0090285) |
0.2 | 0.7 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.2 | GO:0048073 | regulation of eye pigmentation(GO:0048073) |
0.2 | 1.2 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
0.2 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.2 | 5.3 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.2 | 0.7 | GO:0045081 | negative regulation of interleukin-10 biosynthetic process(GO:0045081) |
0.2 | 0.7 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.2 | 0.4 | GO:0000294 | nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay(GO:0000294) |
0.2 | 1.1 | GO:0030311 | poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.2 | 0.6 | GO:2000118 | regulation of sodium-dependent phosphate transport(GO:2000118) |
0.2 | 0.6 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.2 | 1.3 | GO:0061364 | apoptotic process involved in luteolysis(GO:0061364) |
0.2 | 0.2 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 0.8 | GO:0051710 | cytolysis by symbiont of host cells(GO:0001897) regulation of cytolysis in other organism(GO:0051710) |
0.2 | 2.1 | GO:0032713 | negative regulation of interleukin-4 production(GO:0032713) |
0.2 | 2.7 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.2 | 0.4 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.2 | 0.8 | GO:0002880 | chronic inflammatory response to non-antigenic stimulus(GO:0002545) regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002880) |
0.2 | 0.8 | GO:0051794 | regulation of monophenol monooxygenase activity(GO:0032771) positive regulation of monophenol monooxygenase activity(GO:0032773) catagen(GO:0042637) regulation of catagen(GO:0051794) negative regulation of catagen(GO:0051796) regulation of hair cycle by canonical Wnt signaling pathway(GO:0060901) positive regulation of melanosome transport(GO:1902910) |
0.2 | 1.8 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.2 | 2.5 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.2 | 0.6 | GO:0060488 | orthogonal dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060488) planar dichotomous subdivision of terminal units involved in lung branching morphogenesis(GO:0060489) lateral sprouting involved in lung morphogenesis(GO:0060490) |
0.2 | 2.6 | GO:0009414 | response to water deprivation(GO:0009414) |
0.2 | 1.0 | GO:0072233 | thick ascending limb development(GO:0072023) metanephric thick ascending limb development(GO:0072233) |
0.2 | 0.6 | GO:0002352 | B cell negative selection(GO:0002352) post-embryonic camera-type eye morphogenesis(GO:0048597) |
0.2 | 1.0 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.2 | 0.9 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.6 | GO:0003218 | cardiac left ventricle formation(GO:0003218) |
0.2 | 0.4 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.2 | 0.8 | GO:0035408 | histone H3-T6 phosphorylation(GO:0035408) |
0.2 | 0.6 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.2 | 0.9 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 1.5 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 0.9 | GO:0009257 | 10-formyltetrahydrofolate biosynthetic process(GO:0009257) |
0.2 | 2.0 | GO:0016191 | synaptic vesicle uncoating(GO:0016191) |
0.2 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.2 | 0.5 | GO:0033341 | regulation of collagen binding(GO:0033341) |
0.2 | 0.5 | GO:0060129 | regulation of calcium-independent cell-cell adhesion(GO:0051040) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
0.2 | 1.0 | GO:0071104 | response to interleukin-9(GO:0071104) |
0.2 | 0.2 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.2 | 0.5 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.7 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.2 | 0.2 | GO:0003192 | mitral valve formation(GO:0003192) |
0.2 | 0.8 | GO:0002415 | immunoglobulin transcytosis in epithelial cells mediated by polymeric immunoglobulin receptor(GO:0002415) |
0.2 | 1.0 | GO:0033277 | abortive mitotic cell cycle(GO:0033277) |
0.2 | 0.3 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.2 | 0.7 | GO:1903232 | melanosome assembly(GO:1903232) |
0.2 | 1.3 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.2 | 0.3 | GO:0060066 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) oviduct development(GO:0060066) |
0.2 | 0.8 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.2 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.2 | 0.3 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
0.2 | 0.6 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.2 | 0.6 | GO:0008355 | olfactory learning(GO:0008355) |
0.2 | 0.2 | GO:0033280 | response to vitamin D(GO:0033280) |
0.2 | 0.6 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.2 | 0.5 | GO:1904784 | NLRP1 inflammasome complex assembly(GO:1904784) |
0.1 | 0.4 | GO:0072566 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) positive regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000340) |
0.1 | 0.7 | GO:1904844 | response to L-glutamine(GO:1904844) cellular response to L-glutamine(GO:1904845) |
0.1 | 0.4 | GO:0060734 | regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:0060734) |
0.1 | 0.4 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.1 | 0.9 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
0.1 | 0.4 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.1 | 0.7 | GO:1905007 | positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905007) occluding junction disassembly(GO:1905071) regulation of occluding junction disassembly(GO:1905073) positive regulation of occluding junction disassembly(GO:1905075) |
0.1 | 0.7 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.4 | GO:1990709 | maintenance of synapse structure(GO:0099558) presynaptic active zone organization(GO:1990709) |
0.1 | 1.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 1.1 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.1 | 1.7 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.1 | 1.0 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.1 | 1.4 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.1 | 0.4 | GO:0046963 | 3'-phosphoadenosine 5'-phosphosulfate transport(GO:0046963) 3'-phospho-5'-adenylyl sulfate transmembrane transport(GO:1902559) |
0.1 | 1.1 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.1 | 0.5 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.5 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.1 | 0.4 | GO:0090158 | endoplasmic reticulum membrane organization(GO:0090158) |
0.1 | 0.9 | GO:2000567 | memory T cell activation(GO:0035709) regulation of memory T cell activation(GO:2000567) positive regulation of memory T cell activation(GO:2000568) |
0.1 | 0.5 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.1 | 0.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.1 | 0.6 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.1 | 0.4 | GO:0002541 | activation of plasma proteins involved in acute inflammatory response(GO:0002541) |
0.1 | 0.4 | GO:0002636 | positive regulation of germinal center formation(GO:0002636) |
0.1 | 1.9 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
0.1 | 0.6 | GO:0018101 | protein citrullination(GO:0018101) histone citrullination(GO:0036414) |
0.1 | 0.9 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.1 | 0.4 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.1 | 0.5 | GO:0072139 | glomerular parietal epithelial cell differentiation(GO:0072139) |
0.1 | 1.8 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 2.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.1 | 0.4 | GO:0007113 | endomitotic cell cycle(GO:0007113) |
0.1 | 1.4 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.1 | 0.2 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
0.1 | 0.5 | GO:0002432 | granuloma formation(GO:0002432) |
0.1 | 1.0 | GO:0070383 | DNA cytosine deamination(GO:0070383) |
0.1 | 1.4 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.1 | 0.2 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.1 | 0.4 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 1.2 | GO:0010593 | negative regulation of lamellipodium assembly(GO:0010593) |
0.1 | 1.6 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.1 | 2.3 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.1 | 0.4 | GO:0043311 | positive regulation of eosinophil degranulation(GO:0043311) positive regulation of eosinophil activation(GO:1902568) |
0.1 | 0.2 | GO:0035625 | epidermal growth factor-activated receptor transactivation by G-protein coupled receptor signaling pathway(GO:0035625) |
0.1 | 2.7 | GO:0030322 | stabilization of membrane potential(GO:0030322) |
0.1 | 0.2 | GO:0002277 | myeloid dendritic cell activation involved in immune response(GO:0002277) |
0.1 | 2.1 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.1 | 1.3 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.1 | 0.3 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
0.1 | 2.4 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.1 | 0.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
0.1 | 0.6 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 1.1 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:0021912 | regulation of transcription from RNA polymerase II promoter involved in spinal cord motor neuron fate specification(GO:0021912) |
0.1 | 1.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.1 | 0.3 | GO:0009443 | pyridoxal 5'-phosphate salvage(GO:0009443) |
0.1 | 0.7 | GO:0060157 | urinary bladder development(GO:0060157) |
0.1 | 1.2 | GO:1905247 | positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process(GO:1902961) positive regulation of aspartic-type peptidase activity(GO:1905247) |
0.1 | 0.1 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.1 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:0042816 | vitamin B6 metabolic process(GO:0042816) |
0.1 | 0.2 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.1 | 0.4 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.3 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.1 | 2.7 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.3 | GO:1902396 | protein localization to bicellular tight junction(GO:1902396) |
0.1 | 1.1 | GO:0038129 | ERBB3 signaling pathway(GO:0038129) |
0.1 | 1.4 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 1.8 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.2 | GO:0035880 | embryonic nail plate morphogenesis(GO:0035880) |
0.1 | 0.3 | GO:0043318 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) regulation of cytotoxic T cell degranulation(GO:0043317) negative regulation of cytotoxic T cell degranulation(GO:0043318) |
0.1 | 1.2 | GO:0048298 | positive regulation of isotype switching to IgA isotypes(GO:0048298) |
0.1 | 0.3 | GO:0097114 | NMDA glutamate receptor clustering(GO:0097114) |
0.1 | 0.8 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.5 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) interleukin-3-mediated signaling pathway(GO:0038156) |
0.1 | 3.0 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.1 | 0.6 | GO:0019747 | regulation of isoprenoid metabolic process(GO:0019747) |
0.1 | 0.4 | GO:0072138 | mesenchymal cell proliferation involved in ureteric bud development(GO:0072138) |
0.1 | 1.4 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 1.6 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.3 | GO:0016256 | N-glycan processing to lysosome(GO:0016256) |
0.1 | 2.8 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.1 | 0.6 | GO:0061083 | regulation of protein refolding(GO:0061083) negative regulation of protein refolding(GO:0061084) |
0.1 | 0.3 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.1 | 0.3 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.1 | 0.1 | GO:0001906 | cell killing(GO:0001906) |
0.1 | 0.4 | GO:0021633 | optic nerve structural organization(GO:0021633) |
0.1 | 0.4 | GO:0036229 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 1.0 | GO:0035021 | negative regulation of Rac protein signal transduction(GO:0035021) |
0.1 | 0.9 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) regulation of midbrain dopaminergic neuron differentiation(GO:1904956) |
0.1 | 0.3 | GO:1905000 | regulation of membrane repolarization during atrial cardiac muscle cell action potential(GO:1905000) |
0.1 | 3.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
0.1 | 0.3 | GO:0002725 | negative regulation of T cell cytokine production(GO:0002725) |
0.1 | 1.2 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.4 | GO:1904806 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.4 | GO:0002884 | negative regulation of type IV hypersensitivity(GO:0001808) negative regulation of hypersensitivity(GO:0002884) |
0.1 | 0.6 | GO:0007498 | mesoderm development(GO:0007498) |
0.1 | 0.5 | GO:0051866 | general adaptation syndrome(GO:0051866) |
0.1 | 0.3 | GO:1902908 | regulation of melanosome transport(GO:1902908) |
0.1 | 0.5 | GO:0014005 | microglia differentiation(GO:0014004) microglia development(GO:0014005) |
0.1 | 0.4 | GO:1903507 | negative regulation of nucleic acid-templated transcription(GO:1903507) |
0.1 | 0.2 | GO:2000562 | negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.1 | 0.3 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.1 | 2.4 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.1 | 1.1 | GO:0071907 | determination of digestive tract left/right asymmetry(GO:0071907) |
0.1 | 0.4 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 0.6 | GO:0021796 | cerebral cortex regionalization(GO:0021796) |
0.1 | 0.3 | GO:1901301 | regulation of cargo loading into COPII-coated vesicle(GO:1901301) |
0.1 | 0.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.1 | 1.4 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.3 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 1.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.1 | 1.0 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.1 | 0.6 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.1 | 0.4 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.1 | 0.3 | GO:0006679 | glucosylceramide biosynthetic process(GO:0006679) |
0.1 | 0.3 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.5 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.1 | 1.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.1 | 1.1 | GO:2000580 | positive regulation of microtubule motor activity(GO:2000576) regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000580) positive regulation of ATP-dependent microtubule motor activity, plus-end-directed(GO:2000582) |
0.1 | 2.9 | GO:0048846 | axon extension involved in axon guidance(GO:0048846) neuron projection extension involved in neuron projection guidance(GO:1902284) |
0.1 | 0.4 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.1 | 0.5 | GO:0038112 | interleukin-8-mediated signaling pathway(GO:0038112) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.3 | GO:0019046 | release from viral latency(GO:0019046) |
0.1 | 0.3 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
0.1 | 0.9 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.1 | 0.7 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.1 | 1.5 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.1 | 0.4 | GO:1990569 | UDP-N-acetylglucosamine transport(GO:0015788) UDP-N-acetylglucosamine transmembrane transport(GO:1990569) |
0.1 | 1.9 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.1 | 0.3 | GO:2000830 | vacuolar phosphate transport(GO:0007037) positive regulation of mitotic cell cycle DNA replication(GO:1903465) positive regulation of parathyroid hormone secretion(GO:2000830) |
0.1 | 0.3 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
0.1 | 1.6 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 0.5 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
0.1 | 0.4 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 0.3 | GO:0035508 | positive regulation of myosin-light-chain-phosphatase activity(GO:0035508) |
0.1 | 0.2 | GO:0060382 | regulation of DNA strand elongation(GO:0060382) |
0.1 | 0.8 | GO:0051581 | negative regulation of neurotransmitter uptake(GO:0051581) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.1 | 1.0 | GO:0021759 | globus pallidus development(GO:0021759) |
0.1 | 0.8 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
0.1 | 0.5 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.1 | 0.2 | GO:1900154 | regulation of bone trabecula formation(GO:1900154) negative regulation of bone trabecula formation(GO:1900155) |
0.1 | 0.4 | GO:0071344 | diphosphate metabolic process(GO:0071344) |
0.1 | 0.2 | GO:2000182 | regulation of progesterone biosynthetic process(GO:2000182) |
0.1 | 0.3 | GO:0042247 | morphogenesis of follicular epithelium(GO:0016333) establishment or maintenance of polarity of follicular epithelium(GO:0016334) establishment of planar polarity of follicular epithelium(GO:0042247) |
0.1 | 0.2 | GO:0010921 | regulation of phosphatase activity(GO:0010921) |
0.1 | 0.1 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.1 | 1.0 | GO:0022010 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
0.1 | 0.2 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.1 | 3.3 | GO:0060706 | cell differentiation involved in embryonic placenta development(GO:0060706) |
0.1 | 0.3 | GO:0014063 | negative regulation of serotonin secretion(GO:0014063) |
0.1 | 0.5 | GO:0032100 | positive regulation of response to food(GO:0032097) positive regulation of appetite(GO:0032100) |
0.1 | 0.4 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) optic cup structural organization(GO:0003409) |
0.1 | 1.2 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.1 | 0.2 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.1 | 0.3 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.1 | 0.2 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.3 | GO:0018277 | protein deamination(GO:0018277) |
0.1 | 0.4 | GO:1990180 | mitochondrial tRNA 3'-end processing(GO:1990180) |
0.1 | 0.5 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.7 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
0.1 | 0.9 | GO:0050966 | detection of mechanical stimulus involved in sensory perception of pain(GO:0050966) |
0.1 | 0.5 | GO:0050915 | sensory perception of sour taste(GO:0050915) |
0.1 | 0.4 | GO:1990523 | bone regeneration(GO:1990523) |
0.1 | 0.6 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:0003358 | noradrenergic neuron development(GO:0003358) |
0.1 | 0.4 | GO:0098887 | neurotransmitter receptor transport, endosome to postsynaptic membrane(GO:0098887) |
0.1 | 0.4 | GO:2000329 | peptidyl-lysine oxidation(GO:0018057) negative regulation of T-helper 17 cell lineage commitment(GO:2000329) |
0.1 | 0.2 | GO:2000588 | positive regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000588) |
0.1 | 0.2 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 1.6 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.6 | GO:0044331 | cell-cell adhesion mediated by cadherin(GO:0044331) |
0.1 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.1 | 0.7 | GO:0002480 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent(GO:0002480) |
0.1 | 0.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.1 | 0.6 | GO:0021592 | fourth ventricle development(GO:0021592) |
0.1 | 0.1 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.1 | 0.4 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.1 | 0.3 | GO:1903300 | negative regulation of glucokinase activity(GO:0033132) negative regulation of hexokinase activity(GO:1903300) |
0.1 | 0.4 | GO:0019064 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 0.2 | GO:0015800 | acidic amino acid transport(GO:0015800) L-glutamate transport(GO:0015813) |
0.1 | 0.7 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.2 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.1 | 0.2 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.1 | 1.2 | GO:0060315 | negative regulation of ryanodine-sensitive calcium-release channel activity(GO:0060315) |
0.1 | 0.3 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0007520 | syncytium formation by plasma membrane fusion(GO:0000768) myoblast fusion(GO:0007520) |
0.1 | 0.7 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.5 | GO:0097461 | ferric iron import(GO:0033216) ferric iron import into cell(GO:0097461) ferric iron import across plasma membrane(GO:0098706) |
0.1 | 0.5 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 1.1 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.1 | 0.3 | GO:0010757 | negative regulation of plasminogen activation(GO:0010757) |
0.1 | 0.2 | GO:1903984 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.1 | 0.7 | GO:0002227 | innate immune response in mucosa(GO:0002227) |
0.1 | 0.2 | GO:0048619 | embryonic hindgut morphogenesis(GO:0048619) |
0.1 | 0.9 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.3 | GO:0060979 | vasculogenesis involved in coronary vascular morphogenesis(GO:0060979) |
0.1 | 0.3 | GO:1901857 | positive regulation of cellular respiration(GO:1901857) |
0.1 | 0.5 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
0.1 | 0.7 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.1 | 0.7 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.1 | 0.3 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.1 | 0.5 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.1 | 0.1 | GO:1904526 | regulation of microtubule binding(GO:1904526) |
0.1 | 0.8 | GO:0007258 | JUN phosphorylation(GO:0007258) |
0.1 | 0.3 | GO:0044240 | multicellular organism lipid catabolic process(GO:0044240) |
0.1 | 1.1 | GO:0001562 | response to protozoan(GO:0001562) |
0.1 | 0.2 | GO:1905053 | regulation of base-excision repair(GO:1905051) positive regulation of base-excision repair(GO:1905053) |
0.1 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 1.4 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 0.3 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
0.1 | 0.5 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.1 | 0.8 | GO:0045023 | G0 to G1 transition(GO:0045023) |
0.1 | 0.2 | GO:0003335 | corneocyte development(GO:0003335) |
0.1 | 0.1 | GO:1904398 | positive regulation of neuromuscular junction development(GO:1904398) |
0.1 | 1.6 | GO:0051412 | response to corticosterone(GO:0051412) |
0.1 | 0.1 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.1 | 0.3 | GO:0038183 | bile acid signaling pathway(GO:0038183) |
0.1 | 0.2 | GO:0097212 | cleavage furrow ingression(GO:0036090) lysosomal membrane organization(GO:0097212) |
0.1 | 0.1 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.1 | 0.4 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
0.1 | 0.4 | GO:0038145 | macrophage colony-stimulating factor signaling pathway(GO:0038145) |
0.1 | 0.1 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.1 | 0.5 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 1.1 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.4 | GO:0015798 | myo-inositol transport(GO:0015798) |
0.1 | 1.8 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.8 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) |
0.1 | 4.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.1 | 0.2 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 1.6 | GO:0071526 | semaphorin-plexin signaling pathway(GO:0071526) |
0.1 | 0.2 | GO:0003292 | atrioventricular node development(GO:0003162) cardiac septum cell differentiation(GO:0003292) atrioventricular node cell differentiation(GO:0060922) atrioventricular node cell development(GO:0060928) |
0.1 | 1.2 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) |
0.1 | 0.7 | GO:0035878 | nail development(GO:0035878) |
0.1 | 0.2 | GO:0016267 | O-glycan processing, core 1(GO:0016267) |
0.1 | 0.2 | GO:0021849 | neuroblast division in subventricular zone(GO:0021849) |
0.1 | 0.2 | GO:0035284 | rhombomere 5 development(GO:0021571) central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.1 | 0.3 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 1.4 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.1 | 0.8 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 1.9 | GO:0071800 | podosome assembly(GO:0071800) |
0.1 | 0.2 | GO:2000619 | negative regulation of histone H4-K16 acetylation(GO:2000619) |
0.1 | 0.4 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.1 | 1.0 | GO:1901748 | leukotriene D4 metabolic process(GO:1901748) leukotriene D4 biosynthetic process(GO:1901750) |
0.1 | 0.4 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.2 | GO:1901291 | negative regulation of double-strand break repair via single-strand annealing(GO:1901291) |
0.1 | 0.4 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) positive regulation of store-operated calcium channel activity(GO:1901341) |
0.1 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 0.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
0.1 | 0.3 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.1 | 1.3 | GO:0015669 | gas transport(GO:0015669) oxygen transport(GO:0015671) |
0.1 | 0.2 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 0.4 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
0.1 | 0.3 | GO:1901994 | negative regulation of meiotic cell cycle phase transition(GO:1901994) |
0.1 | 0.8 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.1 | 0.2 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.9 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 0.8 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.1 | 0.2 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.1 | 0.4 | GO:0021681 | cerebellar granular layer development(GO:0021681) |
0.1 | 0.1 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.1 | 0.1 | GO:0009617 | response to bacterium(GO:0009617) |
0.1 | 0.5 | GO:0032264 | IMP salvage(GO:0032264) |
0.1 | 0.3 | GO:1903597 | negative regulation of gap junction assembly(GO:1903597) |
0.1 | 0.6 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
0.0 | 0.4 | GO:0042487 | regulation of odontogenesis of dentin-containing tooth(GO:0042487) |
0.0 | 0.1 | GO:0036100 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.0 | 0.9 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.0 | 0.2 | GO:0032425 | positive regulation of mismatch repair(GO:0032425) |
0.0 | 0.3 | GO:0035162 | embryonic hemopoiesis(GO:0035162) |
0.0 | 0.2 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.0 | 0.4 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.0 | 0.1 | GO:1900736 | negative regulation of phospholipase C activity(GO:1900275) regulation of proteinase activated receptor activity(GO:1900276) regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) negative regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900737) |
0.0 | 0.4 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.0 | 0.6 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.1 | GO:1903909 | excitatory chemical synaptic transmission(GO:0098976) positive regulation of postsynaptic membrane organization(GO:1901628) regulation of receptor clustering(GO:1903909) positive regulation of receptor clustering(GO:1903911) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.0 | 0.2 | GO:0060721 | spongiotrophoblast cell proliferation(GO:0060720) regulation of spongiotrophoblast cell proliferation(GO:0060721) cell proliferation involved in embryonic placenta development(GO:0060722) regulation of cell proliferation involved in embryonic placenta development(GO:0060723) |
0.0 | 0.7 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
0.0 | 0.2 | GO:0048069 | eye pigmentation(GO:0048069) |
0.0 | 1.3 | GO:0060441 | epithelial tube branching involved in lung morphogenesis(GO:0060441) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) calcium ion export from cell(GO:1990034) |
0.0 | 0.5 | GO:1900113 | negative regulation of histone H3-K9 trimethylation(GO:1900113) |
0.0 | 0.2 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.0 | 0.8 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 0.4 | GO:0048245 | eosinophil chemotaxis(GO:0048245) |
0.0 | 0.4 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 3.1 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.5 | GO:0032495 | response to peptidoglycan(GO:0032494) response to muramyl dipeptide(GO:0032495) |
0.0 | 0.2 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.1 | GO:0071529 | cementum mineralization(GO:0071529) |
0.0 | 0.2 | GO:2000434 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.0 | 0.1 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.0 | 0.4 | GO:0032472 | Golgi calcium ion transport(GO:0032472) |
0.0 | 0.5 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.0 | 0.7 | GO:0051923 | sulfation(GO:0051923) |
0.0 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.0 | 0.1 | GO:1904298 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.0 | 0.7 | GO:0060242 | contact inhibition(GO:0060242) |
0.0 | 0.7 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.1 | GO:0046603 | negative regulation of mitotic centrosome separation(GO:0046603) |
0.0 | 0.2 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.3 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
0.0 | 0.1 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.0 | 0.2 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.0 | 0.2 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.0 | 0.6 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.0 | 0.5 | GO:0097396 | response to interleukin-17(GO:0097396) cellular response to interleukin-17(GO:0097398) |
0.0 | 0.1 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.0 | 0.4 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.0 | 0.9 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.0 | 0.2 | GO:0019605 | butyrate metabolic process(GO:0019605) |
0.0 | 0.2 | GO:0099551 | synaptic signaling via neuropeptide(GO:0099538) trans-synaptic signaling by neuropeptide(GO:0099540) trans-synaptic signaling by neuropeptide, modulating synaptic transmission(GO:0099551) |
0.0 | 0.1 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.0 | 0.8 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.0 | 0.2 | GO:0007623 | circadian rhythm(GO:0007623) |
0.0 | 0.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
0.0 | 0.7 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.0 | 1.3 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.8 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0042137 | sequestering of neurotransmitter(GO:0042137) |
0.0 | 0.4 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.0 | 0.4 | GO:0097338 | response to clozapine(GO:0097338) |
0.0 | 0.2 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.0 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 0.2 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.0 | 0.2 | GO:0019303 | D-ribose catabolic process(GO:0019303) |
0.0 | 0.3 | GO:0034316 | negative regulation of Arp2/3 complex-mediated actin nucleation(GO:0034316) |
0.0 | 0.2 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.2 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.0 | 7.5 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
0.0 | 0.1 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.0 | 0.2 | GO:0001554 | luteolysis(GO:0001554) |
0.0 | 0.6 | GO:2000821 | regulation of grooming behavior(GO:2000821) |
0.0 | 0.2 | GO:0070253 | somatostatin secretion(GO:0070253) |
0.0 | 0.5 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.0 | 0.3 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.0 | 0.2 | GO:2000352 | negative regulation of endothelial cell apoptotic process(GO:2000352) |
0.0 | 0.0 | GO:0051464 | positive regulation of cortisol secretion(GO:0051464) |
0.0 | 0.1 | GO:0021577 | hindbrain structural organization(GO:0021577) cerebellum structural organization(GO:0021589) |
0.0 | 0.3 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.0 | 0.3 | GO:0070197 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.0 | 0.2 | GO:0016476 | regulation of embryonic cell shape(GO:0016476) |
0.0 | 0.1 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
0.0 | 0.8 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |